Skip to main content

Table 2 Clinical, ECG, and metabolic details of patients undergoing biliary-pancreatic-diversion (BPD) and laparoscopic gastric banding (LAGB).

From: Biliary pancreatic diversion and laparoscopic adjustable gastric banding in morbid obesity: their long-term effects on metabolic syndrome and on cardiovascular parameters

 

BPD

  

LAGB

  

BEFORE

AFTER

CHANGE

BEFORE

AFTER

CHANGE

N (men, women)

23 (7/16)

  

78 (10/68)

  

Age (y)

45.3 ± 1.78

  

44.2 ± 1.16

  

BMI (kg/m2)

48.6 ± 1.45

30.1 ± 1.26

-18.5 ± 1.43

44.8 ± 0.74 *

35.4 ± 0.61 #

-9.5 ± 0.66 #

Systolic BP (mmHg)

148.3 ± 4.98

121.7 ± 2.86

-26.5 ± 5.16

132.9 ± 1.35 #

128.6 ± 1.69 *

-4.3 ± 1.61 #

Diastolic BP (mmHg)

97.8 ± 3.81

76.3 ± 1.92

-21.5 ± 3.35

82.4 ± 1.04 #

82.6 ± 1.12 *

+0.1 ± 1.26 #

Hypertension (y/n)

12/11

1/22

-11

28/50

19/59

-9 (-12, + 3)

Heart rate (bpm)

82.4 ± 3.63

69.8 ± 2.22

-12.6 ± 2.98

79.8 ± 1.31

66.8 ± 1.09

-13.0 ± 1.36

QTc (msec)

403.5 ± 5.44

388.9 ± 6.27

-14.6 ± 5.83

415.1 ± 3.48

401.6 ± 3.09

-13.5 ± 3.54

Cornell-voltage (mm.ms)

1612.6 ± 155.48

1249.6 ± 144.63

-391.4 ± 172.87

1545.9 ± 59.69

1523.8 ± 59.62

-22.2 ± 54.97 **

RPP

122.9 ± 7.79

85.4 ± 3.84

-37.5 ± 6.96

105.9 ± 1.92 *

86.4 ± 1.71

-19.5 ± 2.19 **

LVH (y/n) °

8/15

2/21

-6

23/55

26/52

+3 (-6, +9) *

Cholesterol (mg/dl)

210.1 ± 9.78

133.8 ± 6.43

-76.3 ± 11.48

200.5 ± 4.75

205.8 ± 5.26 #

+5.3 ± 3.82 #

Triglycerides (mg/dl)

190.4 ± 45.58

83.3 ± 7.02

-107.0 ± 48.33

149.6 ± 12.32

108.1 ± 7.69 *

-41.4 ± 10.31

Blood glucose (mg/dl)

98.8 ± 7.66

82.1 ± 2.13

-16.7 ± 6.94

108.4 ± 4.04

93.7 ± 2.31 **

-14.7 ± 3.49

Diabetes mellitus (y/n)

2/21

0/23

-2

12/66

4/74

-8

Metabolic Syndrome (y/n)

5/18

0/23

-5

25/53

11/67

-14

  1. Means ± SE or absolute frequencies.
  2. ° as defined by ECG criteria
  3. * = p < 0.05; ** = p < 0.01; # = p < 0.001 vs corresponding values of BPD